Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1812320230400030241
Journal of Yeungnam Medical Science
2023 Volume.40 No. 3 p.241 ~ p.246
Advances in management of pediatric chronic immune thrombocytopenia: a narrative review
Lee Jae-Min
Abstract
Immune thrombocytopenia (ITP) is a disease in which thrombocytopenia occurs because of immune-mediated platelet destruction and decreased platelet production. Although many pediatric patients with ITP experience spontaneous remission or reach remission within 12 months of first-line therapy, approximately 20% progress to chronic ITP. Patients who do not respond to first-line treatment or experience frequent relapses are of great concern to physicians. This review summarizes recent treatments for second-line treatment of pediatric chronic ITP.
KEYWORD
Dapsone, Idiopathic thrombocytopenic purpura, Rituximab, Splenectomy, Thrombopoietin
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed